Advertisement

The Latest

2017 is shaping up to be a particularly interesting year in healthcare, one that will likely be full of uncertainty but also opportunity. This extends to the ambulatory surgery center (ASC) industry.

Most investors have concerns about the global economy. We are almost a decade removed from the 2008 financial crisis and have witnessed the S&P 500 index appreciate by nearly 200 percent as of the time of this article.

A recent Congressional Budget Office report found millions will be left without coverage and premiums will increase significantly if legislators dismantle the ACA through the Restoring Americans' Healthcare Freedom Reconciliation Act of 2015.

Rep. Tom Price, MD, (R-Ga.) invested between $1,000 and $15,000 in six pharmaceutical companies during a time when his public office required him to make decisions that would affect the companies' bottom lines, Time reports.

Advertisement